Development of Drug Creation Business through Licensing Out
The Company concentrates management resources in drug creation which is said to be in the upstream of pharmaceutical business and produces innovative drug candidate compounds. We aim at licensing out the created drug candidate compounds at an early stage. The Company gains revenue by promoting these business models.
The Company’s Business Models Diagram
Our major sales from these business models consist of:
- Front money income to be received at the time of licensing out;
- Milestone income to be received at each milestone as the clinical studies progress; and
- Royalty income to be received at a fixed ratio of the post-launch sales turnover.